These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15154309)

  • 21. Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.
    Ganti AK; Landmark JD; Kessinger A; Smith LM; Tarantolo SR
    In Vivo; 2006; 20(4):559-63. PubMed ID: 16900790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation.
    de Boer MT; Christensen MC; Asmussen M; van der Hilst CS; Hendriks HG; Slooff MJ; Porte RJ
    Anesth Analg; 2008 Jan; 106(1):32-44, table of contents. PubMed ID: 18165548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apheresis platelet transfusions: does ABO matter?
    Herman JH; King KE
    Transfusion; 2004 Jun; 44(6):802-4. PubMed ID: 15157242
    [No Abstract]   [Full Text] [Related]  

  • 24. Transfusion management strategies: a survey of practicing pediatric hematology/oncology specialists.
    Wong EC; Perez-Albuerne E; Moscow JA; Luban NL
    Pediatr Blood Cancer; 2005 Feb; 44(2):119-27. PubMed ID: 15452914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunologically induced diseases. 2. immunologically induced hematologic diseases].
    Baenkler WH
    Fortschr Med; 1976 May; 94(14):801-2,804-6,808. PubMed ID: 1270044
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment of immediate transfusion reaction.
    Baker RJ; Nyhus LM
    Surg Gynecol Obstet; 1970 Apr; 130(4):665-72. PubMed ID: 5436606
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of mismatched blood transfusion reaction.
    Gopalrao T
    J Med Soc N J; 1973 Mar; 70(3):181-4. PubMed ID: 4510801
    [No Abstract]   [Full Text] [Related]  

  • 29. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation.
    Briggs C; Hart D; Kunka S; Oguni S; Machin SJ
    Transfus Med; 2006 Apr; 16(2):101-9. PubMed ID: 16623916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thrombocytopenia: is therapeutic platelet transfusion effective? Prophylactic platelet transfusion remains justified].
    Bethge W
    Dtsch Med Wochenschr; 2012 Dec; 137(50):2630. PubMed ID: 23225185
    [No Abstract]   [Full Text] [Related]  

  • 32. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia.
    Mousset S; Hermann S; Klein SA; Bialleck H; Duchscherer M; Bomke B; Wassmann B; Böhme A; Hoelzer D; Martin H
    Ann Hematol; 2005 Oct; 84(11):734-41. PubMed ID: 15951986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recommendations for platelet transfusion by the Joint Thrombocyte Working Party of the German Societies of Transfusion Medicine and Immunohaematology (DGTI), Thrombosis and Haemostasis Research (GTH), and Haematology and Oncology (DGHO)].
    Greinacher A; Kiefel V; Klüter H; Kroll H; Pötzsch B; Riess H; ; ;
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2675-9. PubMed ID: 17109279
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention and intensive therapy of blood transfusion complications].
    Skachilova NN
    Vestn Khir Im I I Grek; 1982 Oct; 129(10):94-7. PubMed ID: 7179673
    [No Abstract]   [Full Text] [Related]  

  • 35. [The microbial safety of transfusion products].
    Mäki T; Krusius T
    Duodecim; 2004; 120(7):885-92. PubMed ID: 15154310
    [No Abstract]   [Full Text] [Related]  

  • 36. [Directions for allogenic stem cell transplants and how they reflect on the operation and results of the transfer center in Turku].
    Remes K; Luoma S; Salmi TT; Tarja-Terttu P; Itälä M; Kauppila M; Nikoskelainen J; Putkonen M; Kairisto V; Rajamäki A; Tienhaara A; Pyrhönen S; Rauhala A
    Duodecim; 2005; 121(19):2085-97. PubMed ID: 16300297
    [No Abstract]   [Full Text] [Related]  

  • 37. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A.
    Harris SB; Josephson CD; Kost CB; Hillyer CD
    Transfusion; 2007 Aug; 47(8):1412-7. PubMed ID: 17655585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute dyspnoea following transfusion of plasma-containing blood products].
    Becker EA; van Rhenen DJ
    Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1540-1; author reply 1541. PubMed ID: 16033003
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute dyspnoea following transfusion of plasma-containing blood products].
    Kessels LW; Visser OJ
    Ned Tijdschr Geneeskd; 2005 Feb; 149(7):369-71. PubMed ID: 15751810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the economic value of the INTERCEPT blood system in Belgium.
    Moeremans K; Warie H; Annemans L
    Transfus Med; 2006 Feb; 16(1):17-30. PubMed ID: 16480436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.